Kellanova shares surge by 16%
Shares in Pringles maker, Kellanova, hiked by 16% – should you buy?


Shares in Pringles and Pop Tarts maker, Kellanova, surged by 16% this week after it was reported that confectionery, food and pet care conglomerate Mars is preparing to buy it. That would be “one of the year’s biggest takeovers”, says the Financial Times.
Mars is one of the world’s largest privately held companies, with annual sales of more than $50 billion and more than 150,000 employees. The news also comes as Kellanova has “appeared to weather the slowdown in US consumer spending”, raising its full-year sales forecasts last week after its latest earnings “surpassed expectations”. The shares had gained 15% this year before the bid.
Should you buy Kellanova shares?
Buying Kellanova makes sense, say Crystal Tse and Deena Shanker on Bloomberg. It would give Mars “a greater variety of food labels including Pringles, Cheez-It and Pop Tarts”. It would also help Mars diversify its “chocolate-heavy brand portfolio” away from cocoa, “a commodity whose prices have spiked to historic levels this year and whose outlook remains uncertain”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Kellanova would also help Mars fight back against “declining volumes, slowing growth and a weakening global consumer”. While there are other potential acquirers, including Mondelez International, a purchase by Mars would face less regulatory scrutiny as Mars has less overlap with Kellanova than other brands.
The financial logic of the deal “can just about work, too”, says Jennifer Saba on Breakingviews. There could be nearly $1 billion of synergies. However, the timing “may seem odd”, as Procter & Gamble, McDonald’s and even Amazon have noted that shoppers “are becoming much more discerning on price”.
Meanwhile anti-obesity drugs from Novo Nordisk, Eli Lilly and others “threaten consumption of empty-calorie treats”. Still, “if the market is getting tougher, bulking up to take a bigger piece of it is a textbook defence”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Rachel Reeves's Spring Statement: what we know so far
Chancellor Rachel Reeves will deliver her Spring Statement to Parliament on Wednesday, 26 March. Tax changes are not expected but spending cuts could be on the horizon.
By Katie Williams Last updated
-
8 of the best energy-efficient properties for sale
The best energy-efficient properties for sale – from a HUF HAUS in London’s Dulwich Village to a contemporary property in the Lake District National Park
By Natasha Langan Published
-
Find tomorrow’s Asian giants while they are still smaller companies
Opinion Nitin Bajaj, portfolio manager of the Fidelity Asian Values trust, picks three Asian companies to invest in.
By Nitin Bajaj Published
-
AI will maintain Moody’s market lead, says Stephen Connolly
Opinion Veteran data provider Moody's has adapted well to the modern world, and is one of Warren Buffett’s longest-held investments
By Stephen Connolly Published
-
Is BlackRock World Mining gearing for a recovery?
Opinion After a frustrating year, BlackRock World Mining is positioned for growth and to capitalise on the sector's recovery
By Rupert Hargreaves Published
-
Should you limit exposure to US tech stocks?
An end to the AI boom would shake both US funds and global trackers. Here’s one way to trim exposure to US tech stocks
By Cris Sholto Heaton Published
-
The mystery of America’s gold and why an audit matters
How much gold does the US actually have? Dominic Frisby explains why it matters
By Dominic Frisby Published
-
Art vs AI: artists’ uprising takes on the bots
AI performs impressively, but it’s all based on human work that was taken without payment. The government thinks this is fine. Copyright holders beg to differ
By Simon Wilson Published
-
The benefits of a stock bubble
Opinion We tend to think of stock bubbles as bad things but, as the dotcom craze shows, good things can come from them, says Matthew Lynn
By Matthew Lynn Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published